S.T. DUPONT (DPT.PA) Fundamental Analysis & Valuation

EPA:DPT • FR0000054199

Current stock price

0.0898 EUR
0 (0%)
Last:

This DPT.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. DPT.PA Profitability Analysis

1.1 Basic Checks

  • DPT had negative earnings in the past year.
  • In the past year DPT had a positive cash flow from operations.
  • DPT had negative earnings in 4 of the past 5 years.
  • In multiple years DPT reported negative operating cash flow during the last 5 years.
DPT.PA Yearly Net Income VS EBIT VS OCF VS FCFDPT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M -10M

1.2 Ratios

  • DPT's Return On Assets of 1.31% is on the low side compared to the rest of the industry. DPT is outperformed by 63.04% of its industry peers.
  • The Return On Equity of DPT (2.80%) is worse than 65.22% of its industry peers.
  • DPT's Return On Invested Capital of 0.96% is on the low side compared to the rest of the industry. DPT is outperformed by 78.26% of its industry peers.
Industry RankSector Rank
ROA 1.31%
ROE 2.8%
ROIC 0.96%
ROA(3y)-1.58%
ROA(5y)-8.67%
ROE(3y)-59.93%
ROE(5y)-97.15%
ROIC(3y)N/A
ROIC(5y)N/A
DPT.PA Yearly ROA, ROE, ROICDPT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150

1.3 Margins

  • DPT's Profit Margin of 1.34% is on the low side compared to the rest of the industry. DPT is outperformed by 63.04% of its industry peers.
  • DPT's Operating Margin of 0.81% is on the low side compared to the rest of the industry. DPT is outperformed by 78.26% of its industry peers.
  • DPT has a worse Gross Margin (53.62%) than 63.04% of its industry peers.
  • DPT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 0.81%
PM (TTM) 1.34%
GM 53.62%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.87%
GM growth 5Y4.3%
DPT.PA Yearly Profit, Operating, Gross MarginsDPT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. DPT.PA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), DPT is destroying value.
  • The number of shares outstanding for DPT remains at a similar level compared to 1 year ago.
  • DPT has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for DPT has been reduced compared to a year ago.
DPT.PA Yearly Shares OutstandingDPT.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
DPT.PA Yearly Total Debt VS Total AssetsDPT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

  • DPT has an Altman-Z score of 2.86. This is not the best score and indicates that DPT is in the grey zone with still only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.86, DPT is in line with its industry, outperforming 56.52% of the companies in the same industry.
  • DPT has a debt to FCF ratio of 4.27. This is a neutral value as DPT would need 4.27 years to pay back of all of its debts.
  • DPT's Debt to FCF ratio of 4.27 is in line compared to the rest of the industry. DPT outperforms 54.35% of its industry peers.
  • DPT has a Debt/Equity ratio of 0.20. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.20, DPT belongs to the top of the industry, outperforming 82.61% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 4.27
Altman-Z 2.86
ROIC/WACC0.13
WACC7.5%
DPT.PA Yearly LT Debt VS Equity VS FCFDPT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M 30M

2.3 Liquidity

  • A Current Ratio of 1.53 indicates that DPT should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.53, DPT is in line with its industry, outperforming 52.17% of the companies in the same industry.
  • DPT has a Quick Ratio of 1.53. This is a bad value and indicates that DPT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • DPT has a Quick ratio (0.91) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.53
Quick Ratio 0.91
DPT.PA Yearly Current Assets VS Current LiabilitesDPT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. DPT.PA Growth Analysis

3.1 Past

  • DPT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -46.67%.
  • DPT shows a small growth in Revenue. In the last year, the Revenue has grown by 5.06%.
  • The Revenue has been growing slightly by 4.98% on average over the past years.
EPS 1Y (TTM)-46.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-186.67%
Revenue 1Y (TTM)5.06%
Revenue growth 3Y15.21%
Revenue growth 5Y4.98%
Sales Q2Q%-1.84%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DPT.PA Yearly Revenue VS EstimatesDPT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

More info and screens

Find the best growth stocksShow best growing peers

0

4. DPT.PA Valuation Analysis

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
DPT.PA Price Earnings VS Forward Price EarningsDPT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, DPT is valued a bit more expensive than the industry average as 78.26% of the companies are valued more cheaply.
  • Based on the Price/Free Cash Flow ratio, DPT is valued a bit more expensive than the industry average as 65.22% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 34.75
EV/EBITDA 24.76
DPT.PA Per share dataDPT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.01 0.02 0.03 0.04 0.05

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DPT.PA Dividend Analysis

5.1 Amount

  • DPT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DPT.PA Fundamentals: All Metrics, Ratios and Statistics

S.T. DUPONT

EPA:DPT (3/20/2026, 7:00:00 PM)

0.0898

0 (0%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners90.58%
Ins Owner ChangeN/A
Market Cap84.74M
Revenue(TTM)56.37M
Net Income(TTM)756.00K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.5
P/FCF 34.75
P/OCF 20.06
P/B 3.14
P/tB 3.27
EV/EBITDA 24.76
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFY2.88%
OCF(TTM)0
OCFY4.99%
SpS0.06
BVpS0.03
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 1.31%
ROE 2.8%
ROCE 1.3%
ROIC 0.96%
ROICexc 0.96%
ROICexgc 0.99%
OM 0.81%
PM (TTM) 1.34%
GM 53.62%
FCFM 4.33%
ROA(3y)-1.58%
ROA(5y)-8.67%
ROE(3y)-59.93%
ROE(5y)-97.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.87%
GM growth 5Y4.3%
F-Score6
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 4.27
Debt/EBITDA 1.39
Cap/Depr 52.7%
Cap/Sales 3.17%
Interest Coverage 1.3
Cash Conversion 109.91%
Profit Quality 322.62%
Current Ratio 1.53
Quick Ratio 0.91
Altman-Z 2.86
F-Score6
WACC7.5%
ROIC/WACC0.13
Cap/Depr(3y)135.98%
Cap/Depr(5y)90.75%
Cap/Sales(3y)6.98%
Cap/Sales(5y)5.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-46.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-186.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.06%
Revenue growth 3Y15.21%
Revenue growth 5Y4.98%
Sales Q2Q%-1.84%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y82.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y148.3%
FCF growth 3Y-18.27%
FCF growth 5YN/A
OCF growth 1Y208.39%
OCF growth 3Y-5.46%
OCF growth 5Y29.81%

S.T. DUPONT / DPT.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of S.T. DUPONT (DPT.PA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to DPT.PA.


What is the valuation status for DPT stock?

ChartMill assigns a valuation rating of 0 / 10 to S.T. DUPONT (DPT.PA). This can be considered as Overvalued.


What is the profitability of DPT stock?

S.T. DUPONT (DPT.PA) has a profitability rating of 1 / 10.


Can you provide the financial health for DPT stock?

The financial health rating of S.T. DUPONT (DPT.PA) is 4 / 10.